D C Dillon

Summary

Affiliation: Corixa Corporation
Country: USA

Publications

  1. ncbi Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family
    D C Dillon
    Corixa Corporation, Seattle, Washington 98104, USA
    Infect Immun 67:2941-50. 1999
  2. ncbi Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG
    D C Dillon
    Corixa Corporation, Seattle, Washington 98104, USA
    J Clin Microbiol 38:3285-90. 2000
  3. ncbi Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells
    M R Alderson
    Department of Immunology, Corixa Corporation, Seattle, Washington 98104, USA
    J Exp Med 191:551-60. 2000
  4. ncbi Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen
    M J Lodes
    Corixa Corporation, Seattle, Washington 98104, USA
    J Clin Microbiol 39:2485-93. 2001
  5. ncbi Detection of mammaglobin in the sera of patients with breast cancer
    G R Fanger
    Corixa Corporation, Department of Antigen Discovery, Seattle, WA 98104, USA
    Tumour Biol 23:212-21. 2002

Detail Information

Publications5

  1. ncbi Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family
    D C Dillon
    Corixa Corporation, Seattle, Washington 98104, USA
    Infect Immun 67:2941-50. 1999
    ..The human T-cell responses and initial animal studies provide support for further evaluation of this antigen as a possible component of a subunit vaccine for M.tuberculosis...
  2. ncbi Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG
    D C Dillon
    Corixa Corporation, Seattle, Washington 98104, USA
    J Clin Microbiol 38:3285-90. 2000
    ..rCFP-10 could also contribute to the development of a recombinant T-cell diagnostic test capable of detecting exposure to M. tuberculosis...
  3. ncbi Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells
    M R Alderson
    Department of Immunology, Corixa Corporation, Seattle, Washington 98104, USA
    J Exp Med 191:551-60. 2000
    ..9A. The direct identification of antigens using T cells from immune donors will undoubtedly be critical for the development of vaccines to several intracellular pathogens...
  4. ncbi Serological expression cloning and immunological evaluation of MTB48, a novel Mycobacterium tuberculosis antigen
    M J Lodes
    Corixa Corporation, Seattle, Washington 98104, USA
    J Clin Microbiol 39:2485-93. 2001
    ..tuberculosis infection when it is combined with other known immunodominant antigens, such as the 38-kDa antigen...
  5. ncbi Detection of mammaglobin in the sera of patients with breast cancer
    G R Fanger
    Corixa Corporation, Department of Antigen Discovery, Seattle, WA 98104, USA
    Tumour Biol 23:212-21. 2002
    ..Thus, mammaglobin, which is overexpressed and secreted from breast carcinoma cells, is detectable in sera of patients with breast cancer and may provide a rapid screening test for the diagnosis and management of breast cancer...